Hangao Li

机构：Weifang Medical University

发表论文 4 篇 · 总被引 52 次 · h-index 3

代表论文

• Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation (2021 · Aging · 被引 20)
• Effect Of epigallocatechin-3-gallate on the pharmacokinetics of amlodipine in rats (2018 · Xenobiotica · 被引 18)
• Effects of Danshen tablets on pharmacokinetics of amlodipine in rats (2019 · Pharmaceutical Biology · 被引 11)
• Comparative Study on Population Ecological Distribution and Extracellular Enzyme Activities of Endophytic Fungi in <i>Artemisia annua</i> (2019 · Journal of Biosciences and Medicines · 被引 3)